Best TWAS P=6.44e-68 · Best GWAS P=5.51e-89 conditioned to NaN
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | CLPTM1 | 0.11 | 0.09 | enet | 10 | 0.08 | 2.0e-10 | 3.41 | -5.6 | 2.2e-08 | -0.01 | 1.00 | 0.00 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | PVRL2 | 0.10 | 0.03 | lasso | 2 | 0.03 | 9.2e-05 | -1.44 | -7.5 | 6.9e-14 | -0.07 | 0.68 | 0.03 | TRUE |
3 | GTEx | Adipose Subcutaneous | CEACAM19 | 0.13 | 0.11 | enet | 9 | 0.12 | 4.6e-10 | 5.49 | 5.2 | 1.9e-07 | -0.11 | 0.98 | 0.00 | FALSE |
4 | GTEx | Adipose Visceral Omentum | ZNF285 | 0.17 | 0.05 | enet | 20 | 0.07 | 1.3e-04 | -2.45 | -12.9 | 7.7e-38 | 0.17 | 0.39 | 0.15 | FALSE |
5 | GTEx | Cells Transformed fibroblasts | CEACAM19 | 0.35 | 0.26 | lasso | 2 | 0.28 | 8.7e-21 | 5.49 | 5.2 | 1.7e-07 | -0.12 | 1.00 | 0.00 | TRUE |
6 | GTEx | Liver | PVRL2 | 0.29 | 0.24 | lasso | 4 | 0.21 | 1.4e-06 | -5.66 | 5.5 | 3.1e-08 | 0.12 | 0.21 | 0.05 | TRUE |
7 | GTEx | Skin Not Sun Exposed Suprapubic | ZNF229 | 0.28 | 0.09 | enet | 58 | 0.08 | 2.2e-05 | -2.58 | -13.1 | 2.0e-39 | -0.03 | 0.17 | 0.16 | TRUE |
8 | GTEx | Stomach | BCAM | 0.33 | 0.00 | enet | 3 | 0.01 | 9.6e-02 | 3.08 | -5.9 | 3.0e-09 | 0.09 | 0.07 | 0.07 | FALSE |
9 | GTEx | Thyroid | CEACAM19 | 0.34 | 0.28 | enet | 26 | 0.30 | 9.9e-24 | 5.49 | 8.9 | 3.4e-19 | -0.18 | 1.00 | 0.00 | TRUE |
10 | YFS | Blood | TOMM40 | 0.04 | 0.00 | bslmm | 371 | 0.01 | 2.6e-04 | -9.22 | 8.8 | 1.0e-18 | 0.09 | 0.03 | 0.36 | TRUE |
11 | The Cancer Genome Atlas | Glioblastoma Multiforme | GEMIN7 | 0.24 | 0.05 | lasso | 3 | 0.13 | 9.6e-05 | 7.08 | 6.5 | 9.2e-11 | -0.14 | 0.01 | 0.70 | TRUE |
12 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | CEACAM16 | 0.04 | 0.00 | enet | 6 | 0.02 | 1.4e-03 | -4.56 | 6.0 | 2.2e-09 | -0.17 | 0.03 | 0.06 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | APOC1P1 | 0.05 | 0.03 | blup | 37 | 0.03 | 5.2e-04 | -10.77 | 16.3 | 4.6e-60 | 0.53 | 0.14 | 0.20 | FALSE |
14 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | PVR | 0.08 | 0.10 | lasso | 4 | 0.09 | 9.8e-11 | -5.79 | -5.3 | 9.3e-08 | 0.06 | 0.00 | 1.00 | FALSE |
15 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | TOMM40 | 0.04 | 0.03 | lasso | 2 | 0.02 | 1.4e-03 | -17.48 | 17.4 | 6.4e-68 | 0.65 | 0.12 | 0.09 | TRUE |
16 | The Cancer Genome Atlas | Brain Lower Grade Glioma | APOC4 | 0.06 | 0.03 | blup | 34 | 0.04 | 8.4e-06 | 0.41 | 6.5 | 7.8e-11 | 0.14 | 0.70 | 0.02 | TRUE |
17 | The Cancer Genome Atlas | Brain Lower Grade Glioma | CEACAM19 | 0.08 | 0.05 | lasso | 4 | 0.05 | 3.3e-06 | 5.49 | 5.4 | 5.7e-08 | -0.13 | 0.01 | 0.98 | FALSE |
18 | The Cancer Genome Atlas | Lung Adenocarcinoma | NKPD1 | 0.03 | 0.00 | blup | 37 | 0.01 | 4.5e-02 | 4.76 | -6.0 | 2.5e-09 | 0.12 | 0.02 | 0.47 | TRUE |
19 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | APOC1 | 0.05 | 0.00 | blup | 47 | 0.01 | 4.3e-02 | 0.34 | -12.8 | 1.6e-37 | 0.32 | 0.01 | 0.06 | FALSE |
20 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | APOE | 0.06 | 0.00 | blup | 49 | 0.01 | 4.5e-02 | 0.34 | -9.7 | 3.3e-22 | 0.19 | 0.02 | 0.06 | FALSE |
21 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | APOC2 | 0.18 | 0.12 | enet | 14 | 0.13 | 5.2e-06 | 0.41 | 8.8 | 1.1e-18 | -0.11 | 0.65 | 0.03 | TRUE |
22 | The Cancer Genome Atlas | Prostate Adenocarcinoma | CEACAM19 | 0.15 | 0.08 | lasso | 3 | 0.07 | 4.0e-08 | 5.49 | 5.4 | 6.0e-08 | -0.12 | 0.01 | 0.99 | FALSE |
23 | The Cancer Genome Atlas | Prostate Adenocarcinoma | TOMM40 | 0.08 | 0.07 | enet | 13 | 0.07 | 2.2e-07 | -17.48 | 10.9 | 9.8e-28 | 0.67 | 1.00 | 0.00 | FALSE |
24 | The Cancer Genome Atlas | Soft Tissue Sarcoma | APOC4 | 0.13 | 0.10 | blup | 34 | 0.13 | 3.2e-08 | 4.95 | 8.6 | 5.7e-18 | -0.03 | 0.96 | 0.00 | TRUE |
25 | The Cancer Genome Atlas | Stomach Adenocarcinoma | APOC4 | 0.07 | 0.09 | lasso | 2 | 0.09 | 3.2e-07 | 4.65 | 5.2 | 2.4e-07 | -0.03 | 0.78 | 0.01 | TRUE |
26 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | APOC1P1 | 0.14 | 0.01 | blup | 36 | 0.06 | 3.8e-03 | -1.44 | 10.7 | 1.3e-26 | 0.51 | 0.01 | 0.07 | TRUE |
27 | The Cancer Genome Atlas | Thyroid Carcinoma | CEACAM19 | 0.26 | 0.13 | lasso | 3 | 0.14 | 4.0e-13 | 5.49 | 5.2 | 2.1e-07 | -0.14 | 0.01 | 0.99 | FALSE |
28 | The Cancer Genome Atlas | Thyroid Carcinoma | PVRL2 | 0.09 | 0.05 | blup | 55 | 0.03 | 4.6e-04 | -1.37 | -8.2 | 3.3e-16 | 0.45 | 0.48 | 0.05 | TRUE |
29 | The Cancer Genome Atlas | Thyroid Carcinoma | TOMM40 | 0.05 | 0.07 | lasso | 3 | 0.06 | 1.1e-06 | -15.33 | 14.7 | 9.2e-49 | 0.62 | 0.89 | 0.01 | FALSE |
30 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | APOC2 | 0.20 | 0.14 | enet | 10 | 0.14 | 7.9e-05 | 1.93 | -6.9 | 4.2e-12 | 0.12 | 0.15 | 0.05 | FALSE |